NAYA Alpha Therapeutics
About
NAYA Alpha Therapeutics is a clinical-stage biopharmaceutical company developing next-generation targeted alpha therapies based on astatine-211 and antibodies for oncology. The company focuses on addressing unmet medical needs through innovative precision medicines designed to improve efficacy and patient outcomes. NAYA Alpha Therapeutics is advancing a pipeline of targeted alpha therapies while building a decentralized manufacturing network to enable broader access to these transformative treatments.
Application Domain
Nuclear MedicineHealth-techAdvanced Therapies
Core Business
Design & Product DevelopmentR&DSupply Chain
Representatives
Vice President, Radiopharmaceutical R&D & CMC
NAYA Alpha Therapeutics